Friday, February 19, 2010

Maalox has the "opposite" trademark problem


Here’s a bizarre twist on the “trademark problem”. The Food and Drug Administration (FDA) is ordering Novartis to use a different brand name for its most potent form of “Maalox”, that is, “Maalox Total Relief” because some consumers might not realize it could have other side effects due to containing ingredients chemically similar to aspirin.

A typical story is with Portland OR station KGW and the AP, link (web url) here.

It’s perfectly appropriate for companies to own multiple brands, and sometimes they need to use separate brands to avoid confusing consumers.

I didn’t have any Maalox at home for a picture.

No comments: